Has Meike Uhler received payments from drug or device companies?

Yes. Drug and device makers reported $4,519 in general payments to Meike Uhler across 113 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Meike Uhler did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Meike Uhler come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Meike Uhler

Reproductive Endocrinology · Glenview, ILNPI 1174666705

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 49.2% of the total. 2025 is the largest year on record at $1,615, 4.0 times the $400 reported in 2019.

$4,519in general payments, 2019–2025

Across 113 payments — averaging $39.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ferring Pharmaceuticals Inc.$2K
Granata Bio Corporation$1K
Organon$598
AbbVie$139
Merck$110
Hamilton Thorne, Inc.$52
plus $111 from 4 others

$1,108,729in research payments, 2019–2025

Across 77 payments — averaging $14,399 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Ferring International Pharmascience Center US$1.1M

What the payments were for

Travel & lodging$1,69137%
Food & beverage$2,52456%
Education$3057%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ferring Pharmaceuticals Inc.	60	$2,225
Granata Bio Corporation	2	$1,285
Organon	32	$598
AbbVie	2	$139
Merck	7	$110
Hamilton Thorne, Inc.	2	$52
EMD Serono, Inc.	3	$48
Exeltis, USA Inc.	2	$29
Vertical Pharmaceuticals, LLC	2	$22
Galen US Inc	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MENOPUR$761
Orilissa$115

How this compares

$4,519 in reported general payments places this provider in the 75th percentile of 62 reproductive endocrinology providers in Illinois.

See all reproductive endocrinology providers in Illinois →

Other reproductive endocrinology in Glenview

Anne MartiniGlenview$7K
Christopher SipeGlenview$5K
Edward MarutGlenview$4K
Brian KaplanGlenview$4K
Jane NaniGlenview$3K
John RapisardaGlenview$2K
Susan DaviesGlenview$1K
Karine MatevossianGlenview$973
Laurence JacobsGlenview$813
Eve FeinbergChicago$117K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →